Industry News
Coffee genome sequenced
An international research effort into the genome sequencing of the coffee plant has revealed its 'convergent evolution' with unrelated cacao and tea plants.
[ + ]Patents enabling and supporting medical research and resulting tests, vaccines and treatments
Patents are at the core of enabling genetic tests, treatments, vaccines and cures resulting from medical research, says AusBiotech - contrary to reports stemming from last week's Federal Court decision in the D'Arcy v Myriad Genetics case that claim research is being stifled.
[ + ]Ascend to begin breast cancer, BCC trials in '15
Ascend Biopharmaceuticals aims to commence a phase II trial of BCC treatment candidate ASN-002 in 1H15 and a phase Ib trial of breast cancer candidate ASN-004 in 2H15.
[ + ]Australian scientist re-elected to international science council
Professor David Black has been re-elected as Secretary General of the International Council for Science. [ + ]
The first far ultraviolet spectra of a cometary surface
NASA's Alice ultraviolet (UV) spectrograph, located aboard the European Space Agency's Rosetta comet orbiter, has made the first far ultraviolet spectra of a cometary surface. [ + ]
Antisense's ATL1103 shows promise in acromegaly
Antisense Therapeutics' (ASX:ANP) ATL1103 candidate reduced sIGF-I levels in patients with the growth disorder acromegaly during a phase II trial.
[ + ]Federal court upholds decision on Myriad patent
The Federal Court of Australia has upheld its decision from last year in favour of Myriad Genetics patenting isolated DNA associated with breast cancer gene mutations. [ + ]
Support for Chief Scientist's STEM report
Australia's Chief Scientist, Professor Ian Chubb, has released his recommendations for a strategic approach to science and its related fields. [ + ]
Plants help create happy office vibes
Putting plants in the office makes for happier staff and boosts productivity. [ + ]
Action urged to capitalise on opportunity as Budget tables reveal loss of support
The release of the federal government's Science, Research and Innovation Budget Tables this week reveals the losses of almost $400m to science, research and innovation, prompting AusBiotech to reinforce its calls for urgent and specific action that will drive growth in the biotechnology industry and, therefore, the Australian economy.
[ + ]Australia needs a science strategy
Chief Scientist Ian Chubb has called for a coherent, strategic and long-term approach to science in Australia. [ + ]
GSK to shut down Medicines Research Unit
GSK will cease operation of its research unit at Sydney's Prince of Wales Hospital at the end of the month, laying off eight employees and five contractors. [ + ]
Remote lab program receives international award
A futuristic science education program, which lets high-school students take control of live experiments from anywhere in the country, has received a prestigious award from the UK's Institute of Science and Technology. [ + ]
Pharmaxis to take anti-inflammatory to human trials
Pharmaxis (ASX:PXS) plans to conduct the first human trials of PXS4728A - a drug candidate for inflammatory diseases including COPD and NASH - in 1Q15.
[ + ]More funding for medical research
New treatments, improved research translation and Indigenous youth suicide are some of the areas to benefit from the latest NHMRC grant announcement. [ + ]
